Clinical trial comparing a new NSAID with 2 different dosages and diclofenac in patients with arthralgia in acute phase

: In this study 30 athletes suffering from acute post-traumatic arthralgia were divided into 3 groups: 10 were treated with Amtolmetineguacil at the following dosages, 600 mg by os twice daily the first two days followed by 600 mg once daily for 19 days (Group A1); 10 patients treated with Amtolmetineguacil 600 mg twice daily for 21 days (Group A2); 10 patients treated with diclofenac 50 mg twice daily by os for 21 days (Group V). The dosage used in Group A1 was as efficacious as that used in Group A2. Furthermore Amtolmetineguacil was better tolerated than diclofenac.